Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C7H9NO3 |
| Molecular Weight | 155.1513 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1OC(=O)N(CC=C)C1=O
InChI
InChIKey=XWZXRENCCHMZNF-UHFFFAOYSA-N
InChI=1S/C7H9NO3/c1-3-4-8-6(9)5(2)11-7(8)10/h3,5H,1,4H2,2H3
| Molecular Formula | C7H9NO3 |
| Molecular Weight | 155.1513 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Allomethadione is an anticonvulsant. It was used for the treatment of epilepsy. Allomethadione appears to have the advantage over tridione (another anticonvulsant) in not producing ataxia or gastric irritation. Photophobia is common in patients taking tridione but allomethadione did not produce photophobia. The drug causes renal damage. The compound has been marketed in Europe.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13045529
0.3 g five times a day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:57 GMT 2025
by
admin
on
Mon Mar 31 18:20:57 GMT 2025
|
| Record UNII |
BFT641Z2YT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
208-389-0
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
m19
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB05337MIG
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
993
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
100000087437
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
526-35-2
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL93070
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
10683
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
DTXSID90862119
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
BFT641Z2YT
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
3666
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY | |||
|
C80254
Created by
admin on Mon Mar 31 18:20:57 GMT 2025 , Edited by admin on Mon Mar 31 18:20:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |